IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C, Saccani S, Lai ML, Pilloni L, Coni PP, Senes G, Faa G, Van den Oord JJ°. I Cattedra.

Slides:

Advertisements

Similar presentations

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.

Advertisements

Triple-Negative Breast Cancer

Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.

Cancer-stroma interactions: role of cancer-associated fibroblasts and mast cells in breast carcinogenesis A Malfettone 1, G Simone 2, R Rossi 3, C Salvatore.

Pure type mucinous carcinoma of the breast with neuroendocrine differentiation: a case report and short review of literature A. D’Amuri, F. Floccari, L.

Pathology Journal Reading

Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,

Maternal and Children Health Care of Shanxi Province

Cell Signaling Lecture 10. Receptor Tyrosine Kinases Regulate cell proliferation, differentiation, cell survival and cellular metabolism The signaling.

Prepared by Dr. Ammar C. Al-Rikabi & Dr. Ghassan Zidan.

HER-2/neu status in human pancreatic adenocarcinoma: comparative study of expression, amplification and aneuploidy.

Examining the carcinogenic potential of pancreatic inflammation in obese mice with maspin staining Janessa Pennington 1, Mariah Gawlik 1, Betty Herndon.

Livin in Prognosis of Childhood ALL Livin- member of inhibitor of apoptosis proteins (IAP). – IAP- acts on effector and initiator caspases Function of.

Appendix Supplementary data (online only) to: Marleen Kok, Wilbert Zwart, Caroline Holm, Renske Fles, Michael Hauptmann, Laura J. Van ’t Veer, Lodewyk.

The Effect of BRCA1 on the Progesterone Receptor.

Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.

Functional interactions between calmodulin and estrogen receptor-α

INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,

FLEXGene Repository Applications. Exploiting FLEXGene Genes FLEXGene Clones Expression Clones Proteins Protein Expression Localization Interaction Functional.

Role of CXCR4 and VEGF expression and metastatic locoregional lymphnodes in rectal carcinoma Tatangelo F.*, Avallone A.**, Delrio P.°, Scala S.§, Botti.

Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.

Small....but lethal.

Prognostic and Predictive Factors: Current Evidence for Individualized Therapy Predictive Molecular Markers: Hormone Receptor Status Presented by Kathleen.

ABSENCE OF TTF-1 EXPRESSION IN INVASIVE DUCTAL CARCINOMAS-NOS OF BREAST M. Bisceglia, M. Vairo, L. Zaffarano, G. Perrone, M. Cassano, A. Danza. Department.

EXPRESSION OF HER-2 CORRELATED PROTEINS IN ILEAL CARCINOIDS Azzoni C., Giordano G., Bottarelli L., Tamburini E., D’Adda T., Pizzi S., Rindi G., Bordi C.

12 th European Congress on Digital Pathology previously European Congress on Telepathology and international Congress on Virtual Microscopy College des.

Products > HCC1937 Transfection Reagent (Breast Carcinoma) Altogen Biosystems offers the HCC1937 Transfection Reagent among a host of 100+ cell line specific.

Novel blood and tissue Biomarkers for Breast and Prostate Cancers

Number of brain metastasis

Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,

Estrogen & Estrogen Receptor

Genetics In Breast Cancer

BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.

by Johannes B. K. Schwarz, Nicolas Langwieser, Nicole N

(A) Vascular endothelial growth factor D (VEGF-D) staining in luminal ductal cells with occasional staining in myoepithelial cells of normal breast. (A)

Adenoid cystic carcinoma of the breast from a single-center cohort

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

Nat. Rev. Urol. doi: /nrurol

Volume 25, Issue 4, Pages (December 2018)

Cysteine cathepsins (proteases)—On the main stage of cancer?

Immunohistochemical cellular characteristics.

Representative images of immunohistochemical staining of discoidin domain receptor (DDR)2 in interstitial lung disease (ILD) other than idiopathic pulmonary.

Progesterone receptor nuclear morphology patterns in breast cancer.

Volume 67, Issue 4, Pages (April 2005)

Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.

Heather M. Ames, Christopher K. Bichakjian, Grace Y. Liu, Katherine I

(A) Deduced amino acid sequence of the D2SV cDNA cloned from the mouse heart RNA. The novel 20 amino acid C-terminus (CT) is underlined. (A) Deduced amino.

A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer tissues. A, DEAR1 and SMAD3 immunohistochemical staining in human breast cancer.

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.

Figure 6. Effects of chloride channel-3 (ClC-3) knockdown on the growth of human breast tumors in vivo. (A) Representative images of tumors on day 20 from.

Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.

FAK overexpression in invasive human breast cancer and DCIS

(Handling and Evaluation of Breast Cancer Biopsy)

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

Activation of mTOR signaling (increased phosphorylated S6 ribosomal protein) and loss of inhibition of IRS-1 in human endometrial carcinomas. Activation.

Immunohistochemical analysis of dUTPase in human breast adenocarcinoma

Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.

COX-2, Oct-4, and ALDH-1 expression in the mammary gland.

Reduced klotho expression in pancreatic cancer.

In situ analysis of human breast tissue shows the down-regulation of Spry isoforms in breast cancer. In situ analysis of human breast tissue shows the.

Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.

Ki-67 and ERα immunostaining in the mammary gland.

Vorozole treatment-associated changes in protein abundance of multiple antigens. Vorozole treatment-associated changes in protein abundance of multiple.

Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.

Reduced β-catenin and cyclin D1 expression and increased apoptosis in lactating mammary gland epithelia of DDTg mice. Reduced β-catenin and cyclin D1 expression.

NRP2 expression is associated with prostate cancer progression.

Expression of the angiogenic phenotype in the 4-NQO mouse model of HNSCC. A, tissue sections containing areas of normal, hyperkeratosis, dysplasia, and.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.

Presentation transcript:

IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra Anatomia Patologica, University of Cagliari, Italy. °University Hospitals, Katholieke Universiteit Leuven, Belgium.

Background (1) MELK (Maternal Embryonic Leucine Zipper Kinase) is a member of the snf1/AMPK family of serine- threonine kinases; Its specific targets in normal cells have not been identified yet, and its role is therefore still elusive. However, several studies reported an increased expression of MELK in various tumours compared to normal tissues.

Background (2) In breast cancer cell lines and in breast tumours an elevated expression of MELK was found by semi- quantitative RT-PCR and by Western Blot analysis; MELK, by interaction with and phosphorylation of Bcl-G, a pro-apoptotic member of the Bcl-2 family, has an anti-apoptotic effect on tumour cells growth in vitro. Meng-Lay Lin et al, Breast Cancer Research 2007,9:R17.

The aim of the present study was to assess the expression of MELK by immunohistochemistry, comparing normal mammary tissue and breast tumours.

Design Immunohistochemical studies were performed on frozen sections from 17 consecutive cases of breast cancer and 4 cases of normal mammary gland, using a mouse monoclonal antibody against Melk. Immunostaining was also performed for Estrogen (ER) and Progesteron (PR) Receptors and Cerb-B2.

Results (1) MELK was not expressed in normal mammary gland 7 out of 17 breast tumours examined showed immunoreactivity for MELK. Normal mammary gland Invasive ductal carcinoma (IDC).

A cytoplasmatic staining was present in all 7 cases; 5 cases showed both cytoplasmatic and nuclear stain. All Melk positive tumours were ER and PR positive and Cerb-B2 negative. Results (2) Invasive ductal carcinoma (IDC).

Conclusions Our data show that MELK is expressed by cancer cells in a subgroup of breast tumours. In addition, MELK expression was associated with estrogen and progesteron receptor immunoreactivity. The issue of whether MELK immunostaining may have a prognostic significance in breast cancer needs further studies.